INVO Fertility (IVF) EBT Margin Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 37,671.00 |
| Jun 30, 2025 | 36,541.00 |
| Mar 31, 2025 | -50,441.00 |
| Dec 31, 2024 | 2,145.00 |
| Sep 30, 2024 | 11,220.00 |
| Jun 30, 2024 | -8,557.00 |
| Mar 31, 2024 | 14,091.00 |
| Dec 31, 2023 | 35,500.00 |
| Sep 30, 2023 | 10,796.00 |
| Jun 30, 2023 | 98,400.00 |
| Mar 31, 2023 | -59,399.00 |
| Dec 31, 2022 | -74,644.00 |
| Sep 30, 2022 | -86,528.00 |
| Jun 30, 2022 | -174,603.00 |
| Mar 31, 2022 | -125,055.00 |
| Dec 31, 2021 | 290,771.00 |
| Sep 30, 2021 | 4,866.00 |
| Jun 30, 2021 | 2.59 Mn |
| Mar 31, 2021 | 64,292.00 |
| Sep 30, 2020 | 437,509.00 |
| Jun 30, 2020 | 7.96 Mn |
| Mar 31, 2020 | 343,196.00 |
| Sep 30, 2019 | 225,279.00 |
| Jun 30, 2019 | 860,222.00 |
| Mar 31, 2019 | 97,077.00 |
| Dec 31, 2018 | 43,839.00 |
| Sep 30, 2018 | 7.18 Mn |
| Jun 30, 2018 | 120,104.00 |
| Mar 31, 2018 | 351,834.00 |
| Dec 31, 2017 | -9,812.00 |
| Sep 30, 2017 | 641,396.00 |
| Jun 30, 2017 | 92,903.00 |
| Mar 31, 2017 | 174,910.00 |
| Dec 31, 2016 | 219,581.00 |
| Sep 30, 2016 | -41,206.00 |
| Jun 30, 2016 | -2.53 Mn |